Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_assertion type Assertion NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_head.
- NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_assertion description "[No significant differences in cancer-specific or disease-free survival of stage I-III patients according to polymorphic variants were detected, nor were any differences in cancer-specific or disease-free survival detected when patients were subgrouped according to the MTHFR or MTR genotype groups and dichotomized by p16 hypermethylation status in mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_provenance.
- NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_assertion evidence source_evidence_literature NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_provenance.
- NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_assertion SIO_000772 20549016 NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_provenance.
- NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_assertion wasDerivedFrom befree-20150227 NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_provenance.
- NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_assertion wasGeneratedBy ECO_0000203 NP577205.RAeeu4uFUy3vlgKwYPekGQWMCWT4WrxnCCBJKcoGlliN4130_provenance.